Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Yuman Fong, MD
Memorial Sloan Kettering Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Central Baptist Hospital
Lexington, Kentucky, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Integris Oncology Services
Oklahoma City, Oklahoma, United States
- University Medical Group
Providence, Rhode Island, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2003
- Primary completion
- 31 Dec 2004
- Completion
- 31 Dec 2004
- Last update posted
- 6 Jul 2016
- Registered enrollment
- 94
- Registry id
- NCT00063960
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.